Literature DB >> 11505469

Muscularity in adult humans: proportion of adipose tissue-free body mass as skeletal muscle.

Z Wang1, M Heo, R C Lee, D P Kotler, R T Withers, S B Heymsfield.   

Abstract

Muscularity, or the proportion of adipose tissue-free body mass (ATFM) as skeletal muscle (SM), provides valuable body composition information, especially for age-related SM loss (i.e., sarcopenia). Limited data from elderly cadavers suggest a relatively constant SM/ATFM ratio, 0.540 +/- 0.046 for men (mean +/- SD, n = 6) and 0.489 +/- 0.049 for women (n = 7). The aim of the present study was to examine the magnitude and constancy of the SM/ATFM ratio in healthy adults. Whole-body SM and ATFM were measured using multi-scan magnetic resonance imaging. The SM/ATFM ratio was 0.528 +/- 0.036 for men (n = 139) and 0.473 +/- 0.037 for women (n = 165). Multiple regression analysis indicated that the SM/ATFM ratio was significantly influenced by sex, age, body weight, and race. The four factors explained 50% of the observed between individual variation in the SM/ATFM ratio. After adjusting for age, body weight, and race, men had a larger SM/ATFM ratio than women. Both older men and women had a lower SM/ATFM ratio than younger subjects, although the relative reduction was greater in men. After adjustment for sex, age, and body weight, there were no significant differences in the SM/ATFM ratios between Asian, Caucasian, and Hispanic subjects. In contrast, African-American subjects had a significantly greater SM/ATFM ratio than subjects in the other three groups. In addition, the SM/ATFM ratio was significantly lower in AIDS patients than corresponding values in healthy subjects.

Entities:  

Mesh:

Year:  2001        PMID: 11505469     DOI: 10.1002/ajhb.1099

Source DB:  PubMed          Journal:  Am J Hum Biol        ISSN: 1042-0533            Impact factor:   1.937


  23 in total

1.  Volume estimates by imaging methods: model comparisons with visible woman as the reference.

Authors:  Wei Shen; ZiMian Wang; Haiying Tang; Stanley Heshka; Mark Punyanitya; Shankuan Zhu; Jianbo Lei; Steven B Heymsfield
Journal:  Obes Res       Date:  2003-02

2.  Designing Phase II B trials in sarcopenia: the best target population.

Authors:  M Pahor; M Cesari
Journal:  J Nutr Health Aging       Date:  2011-08       Impact factor: 4.075

3.  Skeletal and cardiac myopathy in HIV-1 transgenic rats.

Authors:  Anne M Pruznak; Ly Hong-Brown; Rachel Lantry; Pengxiang She; Robert A Frost; Thomas C Vary; Charles H Lang
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-08-19       Impact factor: 4.310

4.  Sexual size dimorphism, canine dimorphism, and male-male competition in primates: where do humans fit in?

Authors:  J Michael Plavcan
Journal:  Hum Nat       Date:  2012-03

5.  Identifying Low Muscle Mass in Patients with Hip Fracture: Validation of Biolectrical Impedance Analysis and Anthropometry Compared to Dual Energy X-ray Absorptiometry.

Authors:  O M Steihaug; C G Gjesdal; B Bogen; A H Ranhoff
Journal:  J Nutr Health Aging       Date:  2016       Impact factor: 4.075

Review 6.  Obesity and Triple-Negative Breast Cancer: Disparities, Controversies, and Biology.

Authors:  Eric C Dietze; Tanya A Chavez; Victoria L Seewaldt
Journal:  Am J Pathol       Date:  2017-11-09       Impact factor: 4.307

7.  Should the dose of contrast medium be determined solely on the basis of body weight regardless of the patient's sex?

Authors:  Junji Tanaka; Eito Kozawa; Kaiji Inoue; Yasumasa Okamoto; Masahito Toya; Youichi Sato
Journal:  Jpn J Radiol       Date:  2011-06-30       Impact factor: 2.374

8.  Computed Tomography-Measured Psoas Density Predicts Outcomes After Enterocutaneous Fistula Repair.

Authors:  Wilson D Lo; David C Evans; Taehwan Yoo
Journal:  JPEN J Parenter Enteral Nutr       Date:  2017-11-02       Impact factor: 4.016

9.  Sex differences in whole body skeletal muscle mass measured by magnetic resonance imaging and its distribution in young Japanese adults.

Authors:  T Abe; C F Kearns; T Fukunaga
Journal:  Br J Sports Med       Date:  2003       Impact factor: 13.800

Review 10.  Target population for clinical trials on sarcopenia.

Authors:  M Cesari; M Pahor
Journal:  J Nutr Health Aging       Date:  2008 Aug-Sep       Impact factor: 4.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.